E3 PreliminaryPreliminaryPEM ?Case-ControlPeer-reviewedMachine draft
EEG biofeedback as a treatment for chronic fatigue syndrome: a controlled case report.
James, L C, Folen, R A · Behavioral medicine (Washington, D.C.) · 1996 · DOI
Quick Summary
This study tested whether a brain training technique called EEG neurofeedback could help a person with chronic fatigue syndrome (CFS). The patient received this treatment and was tested before and after using standard cognitive (thinking) tests. The results showed improvements in memory, thinking skills, daily functioning, and overall quality of life.
Why It Matters
This early exploration of EEG neurofeedback suggests a potential neuromodulation-based approach for CFS cognitive symptoms, which could open new treatment avenues if validated. Understanding mechanisms that might improve cognition and function in CFS is clinically important given the substantial cognitive burden many patients experience.
Observed Findings
- Improvements in pre- and posttest scores on the Wechsler Adult Intelligence Scale-Revised
- Patient-reported improvements in cognitive abilities
- Enhanced functional skill level following treatment
- Increased quality of life ratings
Inferred Conclusions
- EEG neurofeedback may improve cognitive function in CFS patients
- The intervention appeared to enhance both objective cognitive performance and subjective functional outcomes
Remaining Questions
- Would similar improvements be observed in other CFS patients, or was this response idiosyncratic?
- How much of the improvement was due to the specific EEG neurofeedback mechanism versus placebo, expectation, or natural fluctuation?
- What specific EEG parameters or brain regions were targeted, and are they pathologically altered in CFS?
- How durable are these improvements over longer follow-up periods?
What This Study Does Not Prove
This single case report cannot establish that EEG neurofeedback is an effective CFS treatment—the improvement could reflect placebo effect, natural variation, learning effects from repeated testing, or coincidental life changes. A single patient's response cannot be generalized to the broader CFS population, and without proper controls, causality cannot be determined.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:Neuroimaging
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleExploratory Only